Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 13, 2025Frontiers in MedicineOpen Access

Drugs against osteoporosis in perimenopausal and postmenopausal women

View Full Paper
Ask AI
Bookmark
Share

Authors

HLHong LvYZYaoyang ZhangJLJiaqian Li

Discussion

Loading...

Member takes

Overview

This overview reveals how osteoporosis treatments, including bisphosphonates and hormone therapy, influence bone health in postmenopausal women.

Key Points

  • This research aims to explore the effectiveness of different drug categories for treating osteoporosis in postmenopausal women.
  • Describes categories of osteoporosis drugs: anti-resorptive, anabolic, and phytoestrogens.
  • Reviews mechanisms affecting osteoclast and osteoblast functions.
  • Lists common examples of medications in each category.
  • Anti-resorptive drugs like bisphosphonates and denosumab prevent bone resorption, improving bone density.
  • Anabolic drugs such as teriparatide stimulate new bone growth.
  • Phytoestrogens exhibit estrogenic properties, potentially supporting bone health.

Cite This Study

Lv et al. (2025) studied this question.

synapsesocial.com/papers/692523c1c0ce034ddc354d9ehttps://doi.org/10.3389/fmed.2025.1682333
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Recent Advances in Osteoporosis Therapeutics2025
  2. 2Proactive Intervention and Multidimensional Collaboration: Prevention and Comprehensive Management of Osteoporosis in Perimenopausal and Postmenopausal Women2026
  3. 3Osteoporosis Treatment Strategies: Current Concepts2024 · 2 citations
  4. 4ADVANCES IN OSTEOPOROSIS MANAGEMENT: PATHOPHYSIOLOGY, THERAPEUTIC STRATEGIES, AND EMERGING MOLECULAR TARGETS2026
  5. 5The Current Status of Sequential Therapy with Commonly Used Anti-Osteoporosis Drugs2024